Reply To: Plume?

#131737
DeeAnn Hopings
AMBASSADOR

Ah, found the information that I had previously posted…

https://www.bumc.bu.edu/endo/clinics/transgender-medicine/guidelines/

This link from the Boston University School of Medicine includes the medication and monitoring regimes for F>M and M>F.

Monitoring for transgender women (MTF) on hormone therapy:

  1. Monitor for feminizing and adverse effects every 3 months for first year and then every 6– 12 months.
  2. Monitor serum testosterone and estradiol at follow-up visits with a practical target in the female range (testosterone 30 – 100 ng/dl; E2 <200 pg/ml).
  3. Monitor prolactin and triglycerides before start- ing hormones and at follow-up visits.
  4. Monitor potassium levels if the patient is taking spironolactone.
  5. BMD screening before starting hormones for patients at risk for osteoporosis. Otherwise, start screening at age 60 or earlier if sex hormone levels are consistently low.
  6. MTF patients should be screened for breast and prostate cancer appropriately.

 

©2024 Transgender Heaven | Privacy | Terms of Service | Contact Vanessa

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Transgender Heaven.

You have Successfully Subscribed!

Login to Transgender Heaven

Log in with your credentials

Forgot your details?